Ledger.Open graph →
SEC Form D · filed March 13, 2018

Fortress Biotech, Inc

Offering
$30.0M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Malcolm A. Hoenlein · New York, NYDirectorLindsay A. Rosenwald · New York, NYExec · DirectorJ. J. Lobell · New York, NYDirectorJimmie A. Harvey, Jr · New York, NYDirectorDov K. Klein · New York, NYDirectorEric K. Rowinsky · New York, NYDirectorMichael S. Weiss · New York, NYExec · DirectorGeorge K. Avgerinos · New York, NYExecRaymond S. Chan · New York, NYDirectorJulianne J. Hull · BOSTON, MADirectorSteve Traxler · Chicago, ILExec · DirectorJeffrey Dachis · New York, NYExec · DirectorRichard V. Kretz · Avon, CTDirectorBernard J. Zahren · Avon, CTDirectorIvan Q. Zinn · New York, NYDirectorSpencer J. Raymond · Boston, MAExecRobyn A. Hunter · New York, NYExecJohn S. Struck · Hamilton, BermudaExec · DirectorEthan Kay · Irvine, CAExec · DirectorPhilippe S. Schaison · Newport Beach, CADirectorDouglas Bateson · Wilton, CTDirectorChristina Lampe-Onnerud · Wilton, CTDirectorPer Onnerud · Wilton, CTDirectorDeclan Shalvey · Wilton, CTDirectorMark Van Der Zwan · WEST CONSHOHOCKEN, PAExecRobyn A. Hunter · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗